[go: up one dir, main page]

DK0775129T3 - 3-Benzoylbenzofuranderivater som thyroidhormonantagonister - Google Patents

3-Benzoylbenzofuranderivater som thyroidhormonantagonister

Info

Publication number
DK0775129T3
DK0775129T3 DK95929866T DK95929866T DK0775129T3 DK 0775129 T3 DK0775129 T3 DK 0775129T3 DK 95929866 T DK95929866 T DK 95929866T DK 95929866 T DK95929866 T DK 95929866T DK 0775129 T3 DK0775129 T3 DK 0775129T3
Authority
DK
Denmark
Prior art keywords
pct
thyroid hormone
hormone antagonists
sec
alkyl
Prior art date
Application number
DK95929866T
Other languages
Danish (da)
English (en)
Inventor
Charlotta Mellin
Original Assignee
Karobio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karobio Ab filed Critical Karobio Ab
Application granted granted Critical
Publication of DK0775129T3 publication Critical patent/DK0775129T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95929866T 1994-08-11 1995-08-11 3-Benzoylbenzofuranderivater som thyroidhormonantagonister DK0775129T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416219A GB9416219D0 (en) 1994-08-11 1994-08-11 Receptor ligands
PCT/EP1995/003214 WO1996005190A1 (fr) 1994-08-11 1995-08-11 Derives de 3-benzoyle benzofurane en tant qu'antagonistes de l'hormone thyroidienne

Publications (1)

Publication Number Publication Date
DK0775129T3 true DK0775129T3 (da) 1999-06-28

Family

ID=10759723

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95929866T DK0775129T3 (da) 1994-08-11 1995-08-11 3-Benzoylbenzofuranderivater som thyroidhormonantagonister

Country Status (12)

Country Link
US (1) US5854282A (fr)
EP (1) EP0775129B1 (fr)
JP (1) JPH10504297A (fr)
KR (1) KR970704725A (fr)
AT (1) ATE172460T1 (fr)
AU (1) AU694551B2 (fr)
CA (1) CA2197185A1 (fr)
DE (1) DE69505542T2 (fr)
DK (1) DK0775129T3 (fr)
ES (1) ES2123287T3 (fr)
GB (1) GB9416219D0 (fr)
WO (1) WO1996005190A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058519A1 (fr) * 1998-05-12 1999-11-18 American Home Products Corporation Acides phenyl-oxo-acetiques utiles dans le traitement de l'insulinoresistance et de l'hyperglycemie
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6317722B1 (en) * 1998-09-18 2001-11-13 Amazon.Com, Inc. Use of electronic shopping carts to generate personal recommendations
FR2803846B1 (fr) 2000-01-17 2002-04-05 Clariant France Sa 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, son procede de preparation et son utilisation
GB0015205D0 (en) 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
FR2817864B1 (fr) 2000-12-11 2003-02-21 Sanofi Synthelabo Derive de methanesulfonamido-benzofurane, son procede de preparation et son utilisation comme intermediaire de synthese
KR20040030818A (ko) * 2001-07-20 2004-04-09 카로 바이오 아베 심방 세동의 치료에 있어서의 벤조 퓨란 및 이들의 용도
DE10237819A1 (de) * 2002-08-19 2004-03-04 Bayer Ag 5-Nitrobenzofurane
CA2546601A1 (fr) * 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Nouvelles substances thyromimetiques contenant du phosphore
FR2864536B1 (fr) * 2003-12-24 2006-03-17 Clariant France Sa Procede de preparation de n-alkyl-2 (hydroxy-4-benzoyl)-3 benzofurannes et intermediaires pour sa mise en oeuvre
RU2007148927A (ru) * 2005-05-26 2009-07-10 Метабэйзис Терапьютикс, Инк. (Us) Новые тиреомиметики, содержащие фосфиновую кислоту
US20090232879A1 (en) 2005-05-26 2009-09-17 Metabasis Therapeutics, Inc. Thyromimetics for the Treatment of Fatty Liver Diseases
GB0611210D0 (en) * 2006-06-07 2006-07-19 Cambrex Karlskoga Ab Process
EP2036887A1 (fr) * 2006-06-28 2009-03-18 Sanwa Kagaku Kenkyusho Co., Ltd Nouveau dérivé hétérocyclique 6-5 bicyclique et utilisation médicale de celui-ci
KR100858357B1 (ko) * 2006-10-02 2008-09-11 (주) 디지탈바이오텍 벤조퓨란계 유도체 화합물을 유효성분으로 함유하는인지기능 장애의 예방 및 치료용 조성물
FR2914644B1 (fr) * 2007-04-06 2009-06-05 Finorga Soc Par Actions Simpli Procede de preparation de 2-(n-butyl)-3-(4-hydroxybenzoyl) -5-nitrobenzofurane
FR2914643B1 (fr) * 2007-04-06 2009-06-05 Finorga Soc Par Actions Simpli Procede de preparation du 2-(n-butyl)-5-nitrobenzofurane
FR2915482B1 (fr) * 2007-04-27 2009-11-27 Finorga Procede de preparation du 2-(n-butyl)-5-nitrobenzofurane.
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
HUP1000010A2 (en) 2010-01-08 2011-11-28 Sanofi Sa Process for producing dronedarone
FR2958290B1 (fr) 2010-03-30 2012-10-19 Sanofi Aventis Procede de preparation de derives de sulfonamido-benzofurane
HUP1000330A2 (en) 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
CN101948455B (zh) * 2010-10-18 2012-11-14 山东邹平大展新材料有限公司 一种2-正丁基-3-(4-羟基苯甲酰基)-5-硝基苯并呋喃的制备方法
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
FR2983198B1 (fr) 2011-11-29 2013-11-15 Sanofi Sa Procede de preparation de derives de 5-amino-benzoyl-benzofurane
EP2617718A1 (fr) 2012-01-20 2013-07-24 Sanofi Procédé de préparation de dronédarone à l'aide d'un réactif dibutylaminopropanol
WO2013121235A2 (fr) 2012-02-13 2013-08-22 Sanofi Procédé de préparation de la dronédarone par retrait du groupe hydroxyle
US9249119B2 (en) 2012-02-14 2016-02-02 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
WO2013124745A1 (fr) 2012-02-22 2013-08-29 Sanofi Procédé pour la préparation de dronédarone par l'oxydation d'un groupe hydroxyle
WO2013178337A1 (fr) 2012-05-31 2013-12-05 Sanofi Procédé pour la préparation de dronédarone par réaction de grignard
JP2020500199A (ja) 2016-11-21 2020-01-09 バイキング・セラピューティクス・インコーポレイテッド グリコーゲン蓄積症の治療方法
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
EA202091979A1 (ru) 2018-03-22 2021-06-22 Вайкинг Терапьютикс, Инк. Кристаллические формы и способы получения кристаллических форм соединения
US12102646B2 (en) 2018-12-05 2024-10-01 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255585A (en) * 1975-10-22 1981-03-10 Centre European De Recherches Pharmacologique Benzoheterocyclic derivatives of phenoxyacetic acid
DE3342624A1 (de) * 1983-11-25 1984-03-29 Heinfried Dr. 4019 Monheim Grote Benzaronderivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
JP2873599B2 (ja) * 1990-03-09 1999-03-24 寿製薬株式会社 新規ベンゾフラン誘導体、尿酸排泄剤及びその製法
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
SE9101509D0 (sv) * 1991-05-17 1991-05-17 Karobio Ab Receptor ligands

Also Published As

Publication number Publication date
ATE172460T1 (de) 1998-11-15
EP0775129B1 (fr) 1998-10-21
AU3345595A (en) 1996-03-07
DE69505542D1 (de) 1998-11-26
ES2123287T3 (es) 1999-01-01
GB9416219D0 (en) 1994-10-05
KR970704725A (ko) 1997-09-06
US5854282A (en) 1998-12-29
CA2197185A1 (fr) 1996-02-22
AU694551B2 (en) 1998-07-23
WO1996005190A1 (fr) 1996-02-22
DE69505542T2 (de) 1999-06-02
JPH10504297A (ja) 1998-04-28
EP0775129A1 (fr) 1997-05-28

Similar Documents

Publication Publication Date Title
DK0775129T3 (da) 3-Benzoylbenzofuranderivater som thyroidhormonantagonister
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
PL338735A1 (en) Fluoropyrazole bisphenylamide based
DK0771197T3 (da) Anvendelse af heterocykliske forbindelser som dopamin-D3-ligander
DK0763031T3 (da) Piperazinderivater
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
TNSN04165A1 (en) Substituted hydroxyethylamines
JO2321B1 (en) 4-phenyl-pyridine derivatives
FI945581A0 (fi) Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina
BR9504132A (pt) Derivados de quinoxalina úteis em terapia
ATE45738T1 (de) 1-cyclopropyl-1,4-dihydro-4-oxo-7-(4-(2-oxo-1,3 dioxol-4-yl-methyl)-1-piperazinyl>-3chinolincarbons|uren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel.
DK0804186T3 (da) Indolditerpenalkaloidforbindelser
DK0720598T3 (da) Phenoxyphenylcyclopentenyl-hydroxyurinstoffer
ATE200482T1 (de) N-substituierte azabicycloheptan-derivate als neuroleptika usw.
PT100682A (pt) Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
BR0116721A (pt) Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina
ATE56967T1 (de) Amidderivate.
ATE150014T1 (de) Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen
GR3035010T3 (en) New derivatives of glycylanilides, preparation and therapeutical application
FI882421A0 (fi) 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvoendning som laekemedel.